Clinical Trial News and Research

RSS
New antibody drug shows promising results to prevent or treat HIV

New antibody drug shows promising results to prevent or treat HIV

New method improves speed and diagnostic efficiency during brain surgery

New method improves speed and diagnostic efficiency during brain surgery

Researcher creates molecular diagnostic system that can quickly identify dangerous bacteria

Researcher creates molecular diagnostic system that can quickly identify dangerous bacteria

Yale researchers identify new genetic defect in brain tumor cells that prevents DNA repair

Yale researchers identify new genetic defect in brain tumor cells that prevents DNA repair

Study paves way for therapies against myeloid-derived suppressor cells that collude with cancer

Study paves way for therapies against myeloid-derived suppressor cells that collude with cancer

New approach helps decide better treatment option for laryngeal cancer

New approach helps decide better treatment option for laryngeal cancer

Autologous hematopoietic cell transplant may induce sustained remission of multiple sclerosis

Autologous hematopoietic cell transplant may induce sustained remission of multiple sclerosis

Mayo Clinic to test vaccine for providing lifelong immunity against precancerous breast lesions

Mayo Clinic to test vaccine for providing lifelong immunity against precancerous breast lesions

UTHealth and Children's Memorial Hermann begin two new clinical trials for pediatric brain cancer

UTHealth and Children's Memorial Hermann begin two new clinical trials for pediatric brain cancer

Sanford clinical study exploring immunotherapy drug to treat patients with advanced esophageal cancer

Sanford clinical study exploring immunotherapy drug to treat patients with advanced esophageal cancer

Novel potassium channel genes could be promising therapeutic targets for alcohol use disorder

Novel potassium channel genes could be promising therapeutic targets for alcohol use disorder

Researchers discover that existing anti-gout drug can reduce severity of opioid withdrawal symptoms

Researchers discover that existing anti-gout drug can reduce severity of opioid withdrawal symptoms

First-time drug trials launched on basis of flimsy, under-scrutinized evidence, say McGill researchers

First-time drug trials launched on basis of flimsy, under-scrutinized evidence, say McGill researchers

Acupuncture improves effectiveness of standard treatment for chronic pain and depression

Acupuncture improves effectiveness of standard treatment for chronic pain and depression

ALCMI and Scancell collaborate to advance cancer vaccine clinical trials in NSCLC patients

ALCMI and Scancell collaborate to advance cancer vaccine clinical trials in NSCLC patients

Orthopaedic research helps nurse recover from knee injury

Orthopaedic research helps nurse recover from knee injury

Hemodialysis patients do not wish to receive treatment for depression, study shows

Hemodialysis patients do not wish to receive treatment for depression, study shows

SLATE clinical trial uses Medtronic Visualase MRI-guided laser ablation system to treat common form of epilepsy

SLATE clinical trial uses Medtronic Visualase MRI-guided laser ablation system to treat common form of epilepsy

Body shaming may contribute to increased health risks

Body shaming may contribute to increased health risks

New gene therapy for Pompe disease may replace currently available treatments

New gene therapy for Pompe disease may replace currently available treatments

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.